What do systematic reviews say?

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

• Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 22 participants
  Low

Stem cell therapy vs control

• Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 272 participants
  Very low

Dinutuximab‐containing immunotherapy vs usual care

The review found no eligible studies for this question.

• Anti‐GD2 antibody‐containing immunotherapy postconsolidation therapy for people with high‐risk neuroblastoma treated… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Retinoic acid post‐consolidation therapy vs no further treatment

The review found no eligible studies for this question.

• Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found